Quantbot Technologies LP purchased a new stake in shares of Innospec Inc. (NASDAQ:IOSP - Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm purchased 15,996 shares of the specialty chemicals company's stock, valued at approximately $1,516,000. Quantbot Technologies LP owned 0.06% of Innospec as of its most recent filing with the Securities & Exchange Commission.
Several other hedge funds and other institutional investors also recently added to or reduced their stakes in IOSP. Tsfg LLC acquired a new stake in Innospec during the first quarter valued at $35,000. Caitong International Asset Management Co. Ltd acquired a new stake in Innospec during the first quarter valued at $121,000. State of Wyoming grew its position in Innospec by 167.0% during the fourth quarter. State of Wyoming now owns 1,976 shares of the specialty chemicals company's stock valued at $217,000 after buying an additional 1,236 shares during the period. Quantinno Capital Management LP acquired a new stake in shares of Innospec in the fourth quarter valued at about $237,000. Finally, R Squared Ltd acquired a new stake in shares of Innospec in the first quarter valued at about $262,000. Institutional investors and hedge funds own 96.64% of the company's stock.
Innospec Price Performance
IOSP traded down $0.50 on Thursday, reaching $87.24. 34,282 shares of the company's stock were exchanged, compared to its average volume of 201,376. The stock has a market cap of $2.17 billion, a PE ratio of 111.90 and a beta of 1.07. Innospec Inc. has a twelve month low of $74.10 and a twelve month high of $128.35. The stock's fifty day moving average price is $84.27 and its 200-day moving average price is $90.03.
Innospec (NASDAQ:IOSP - Get Free Report) last posted its quarterly earnings results on Tuesday, August 5th. The specialty chemicals company reported $1.26 earnings per share for the quarter, topping analysts' consensus estimates of $1.17 by $0.09. The firm had revenue of $439.70 million for the quarter, compared to analyst estimates of $440.70 million. Innospec had a net margin of 1.08% and a return on equity of 10.89%. Innospec's quarterly revenue was up 1.1% on a year-over-year basis. During the same period in the previous year, the business posted $1.39 earnings per share. As a group, research analysts predict that Innospec Inc. will post 6.18 earnings per share for the current fiscal year.
Analyst Ratings Changes
Separately, Wall Street Zen lowered shares of Innospec from a "buy" rating to a "hold" rating in a research report on Tuesday, May 6th. One equities research analyst has rated the stock with a Strong Buy rating, According to data from MarketBeat.com, the stock presently has a consensus rating of "Strong Buy".
Check Out Our Latest Report on Innospec
Innospec Company Profile
(
Free Report)
Innospec Inc develops, manufactures, blends, markets, and supplies specialty chemicals in the United States, rest of North America, the United Kingdom, rest of Europe, and internationally. The company's Fuel Specialties segment offers a range of specialty chemical products that are used as additives in additives in diesel, jet, marine, fuel oil and other fuels.
Featured Stories

Before you consider Innospec, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Innospec wasn't on the list.
While Innospec currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.